Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 CNS 2 Sarcoma 1 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 300 Fluorouracil 272 Bevacizumab 237 Gemcitabine 236 Leucovorin 212 Capecitabine 207 pembrolizumab 201 Nivolumab 158 Irinotecan 158 Cisplatin 150 Specimen Handling 144 Magnetic Resonance Spectroscopy 130 130-nm albumin-bound paclitaxel 118 Paclitaxel 109 durvalumab 107 Cetuximab 104 Radiotherapy 99 atezolizumab 94 Drug Therapy 94 Biopsy 93 tislelizumab 81 Albumin-Bound Paclitaxel 81 Taxes 74 Folfox protocol 68 lenvatinib 67 Carboplatin 66 regorafenib 60 Blood Specimen Collection 60 sintilimab 54 Ipilimumab 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

magrolimab × Gastrointestinal × 1 year × Clear all

NCT05330429 2025-07-01

ELEVATE CRC

Gilead Sciences

Phase 2 Terminated

77 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡